Plasma lipoproteins in patients with chronic renal failure (CRF)

被引：5

作者：

Kimak E. ^{[1
]}

Solski J. ^{[1
]}

Janicka L. ^{[2
]}

Duma D. ^{[1
]}

Zagojska M. ^{[2
]}

机构：

[1] Department of Clinical Analytics, Medical School of Lublin, Lublin

[2] Nephrology Division, District Hospital, Lublin

来源：

International Urology and Nephrology | 1997年 / 29卷 / 5期

关键词：

Chronic Renal Failure; International Urology; Plasma Lipoprotein; Total Cholesterol Concentration; Chronic Renal Failure Patient;

D O I：

10.1007/BF02552207

中图分类号：

学科分类号：

摘要：

The clinical picture in chronic renal failure (CRF) shows great variability depending on age, sex aetiology of disease, grades of renal injury and type of treatment. Significant increases of triglycerides (TG), low-density lipoprotein cholesterol (LDL-chol) and apo B concentrations, significant decreases of high-density lipoprotein cholesterol (HDL-chol) levels and apo A and apo AI concentrations, and no significant changes in total cholesterol (TC) have been shown in CRF patients. Significant increases of TC/HDL-chol, LDL-chol/HDL-chol, apo B/apo AI and apo B/LDL-chol ratios were also demonstrated. That indicates a high risk of atherosclerosis even when total cholesterol levels are in the normal range. There were highly significant and positive correlations between TC/HDL-chol and LDL-chol/HDL-chol ratios, apo B and LDL-chol concentrations were as well as between the apo B/apo AI and LDL-chol/HDL-chol ratios.

引用

页码：597 / 601

页数：4

共 12 条

[1]

Alaupovic P., Attman P.O., Lipid and apolipoprotein profiles of uremic dyslipoproteinemia: Relation to renal function and dialysis, Nephron, 57, (1991)

[2]

Aiyoath L.O., Sirisolee K., Shayakul C., Comparison of lipid abnormalities in continuous ambulatory peritoneal dialysis and hemodialysis patients, Transplant. Proc., 26, (1994)

[3]

Appel G., Lipid abnormalities in renal disease, Kidney Int., 39, (1991)

[4]

Attman P.O., Hyperlipoproteinemia in renal failure: Pathogenesis and perspectives for intervention, Nephrol. Dial. Transplant., 8, (1993)

[5]

Blankestijn P.J., Hemodialysis using high flux membranes improves lipid profiles, Clin. Nephrol., 42, (1994)

[6]

Brown M.S., Goldstein J.L., Kovanen P.T., Regulation of cholesterol by lipoprotein receptors, Science, 212, (1981)

[7]

Dnistrian A.M., Schwartz M.K., Greenberg E.J., Effect of tamoxifen on serum cholesterol and lipoproteins during chemohormonal therapy, Clin. Chim. Acta, 223, (1993)

[8]

Docci D., Capponcini C., Mengozzi S., Effects of different dialysis membranes on lipid and lipoprotein in hemodialysis patients, Nephron, 69, (1995)

[9]

Heremans J.F., Garbonara A.D., Mancini G., Immunochemistry, 2, (1965)

[10]

Ksiazek A., Marczewski K., Sokolowska G., Solski J., Leukopenia with different regenerated hemodialysis membranes, Int. Urol. Nephrol., 16, (1984)

← 1 2 →